Provera Tablets 2.5mg (プロベラ錠2.5mg) Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

provera tablets 2.5mg (プロベラ錠2.5mg)

pfizer pharmaceuticals inc. - medroxyprogesterone acetate - orange tablet with split line, diameter: 6.5 mm, thickness: 2.6 mm

DEPO-PROVERA- medroxyprogesterone acetate injection, suspension United States - English - NLM (National Library of Medicine)

depo-provera- medroxyprogesterone acetate injection, suspension

pharmacia & upjohn company llc - medroxyprogesterone acetate (unii: c2qi4ioi2g) (medroxyprogesterone - unii:hsu1c9yres) - medroxyprogesterone acetate 150 mg in 1 ml - depo-provera ci is indicated for use by females of reproductive potential to prevent pregnancy. limitations of use : the use of depo-provera ci is not recommended as a long-term (i.e., longer than 2 years) birth control method unless other options are considered inadequate [see dosage and administration (2.1) and warnings and precautions (5.1)]. the use of depo-provera ci is contraindicated in the following conditions: - known or suspected pregnancy or as a diagnostic test for pregnancy. - active thrombophlebitis, or current or past history of thromboembolic disorders, or cerebral vascular disease [see warnings and precautions (5.2)] . - known or suspected malignancy of breast [see warnings and precautions (5.3)] . - known hypersensitivity to depo-provera ci (medroxyprogesterone acetate) or any of its other ingredients [see warnings and precautions (5.5)] . - significant liver disease [see warnings and precautions (5.7)] . - undiagnosed vaginal bleeding [see warnings and precautions (5.10)] . depo-provera ci

PROVERA 2.5MG TABLETS Canada - English - Health Canada

provera 2.5mg tablets

pfizer canada ulc - medroxyprogesterone acetate - tablet - 2.5mg - medroxyprogesterone acetate 2.5mg - progestins

Padviram 600 mg/200 mg/245 mg film-coated tablets Ireland - English - HPRA (Health Products Regulatory Authority)

padviram 600 mg/200 mg/245 mg film-coated tablets

rowex ltd - efavirenz; emtricitabine; tenofovir disoproxil - film-coated tablet - 600mg/200mg/245 milligram(s) - antivirals for treatment of hiv infections, combinations; emtricitabine, tenofovir disoproxil and efavirenz

Atripla 600mg200mg245mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

atripla 600mg200mg245mg tablets

gilead sciences international ltd - efavirenz; tenofovir disoproxil fumarate; emtricitabine - tablet - 600mg ; 245mg ; 200mg

Efavirenz 600mg  Emtricitabine 200mg  Tenofovir disoproxil 245mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

efavirenz 600mg emtricitabine 200mg tenofovir disoproxil 245mg tablets

dr reddy's laboratories (uk - efavirenz; tenofovir disoproxil fumarate; emtricitabine - tablet - 600mg ; 245mg ; 200mg

PROVERA PAK 10MG TABLETS Canada - English - Health Canada

provera pak 10mg tablets

pfizer canada ulc - medroxyprogesterone acetate - tablet - 10mg - medroxyprogesterone acetate 10mg - progestins

PROVERA PAK 5MG TABLETS Canada - English - Health Canada

provera pak 5mg tablets

pfizer canada ulc - medroxyprogesterone acetate - tablet - 5mg - medroxyprogesterone acetate 5mg - progestins

PROVERA Tablets 250 Milligram Ireland - English - HPRA (Health Products Regulatory Authority)

provera tablets 250 milligram

pharmacia limited - medroxyprogesterone acetate - tablets - 250 milligram

PROVERA Tablets 500 Milligram Ireland - English - HPRA (Health Products Regulatory Authority)

provera tablets 500 milligram

pharmacia limited - medroxyprogesterone acetate - tablets - 500 milligram